Adjuvant pembrolizumab for melanoma: update from the EORTC 1325-MG/KEYNOTE-054 trial

Alice Indini, Francesco Grossi

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)573-575
Number of pages3
JournalThe Lancet Oncology
Volume22
Issue number5
DOIs
Publication statusPublished - May 2021

ASJC Scopus subject areas

  • Oncology

Cite this